Financials
Financial year 2025
Dr. De Wilde Fernand from Sint-Martens-Latem, company number BE1004052740, closed financial year 2025 with a result of € 364,008 after tax. For that financial year Dr. De Wilde Fernand recorded a gross margin of € 1.3 million and equity of € 971,411. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 971,411
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 364,008
Profit after tax over the fiscal year.
€ 409,910
Cash and bank balances on the last day of the fiscal year.
€ 360,000 paid out
99 % of the profit went to the shareholders, mostly to EQIRIS (100 % of the shares). That is where the money ends up.
People and assets in 2025
9
Average over the fiscal year, from the social balance sheet.
€ 667,883
€ 74,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 115,504
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 42,679
€ 25,195 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 449,437
Supplier invoices still open on the last day of the fiscal year.
€ 207,251
Taxes, VAT and social contributions still to pay.
What happened to Dr. De Wilde Fernand?
What happened at Dr. De Wilde Fernand in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 364,008. Source: NBB ↗
- Signifeye NV became a director. NBB
- Eqiris NV became a director. NBB
- New establishment in Merelbeke-Melle. KBO
- New establishment in Eeklo. KBO
- New establishment in Sint-Martens-Latem. KBO
- New establishment in Gavere. KBO
- Fernand De Wilde became a director. NBB
In short
Paid € 118,279 in corporate taxes since 2025.
On average € 143,600 of value added per employee in 2025.
Paid out € 360,000 in dividends to the owners in total.
Management
The stake of EQIRIS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Dr. De Wilde FernandBehind Dr. De Wilde Fernand are Fernand De Wilde, Signifeye NV and Eqiris NV. The shares are held by EQIRIS (100%).
Directors
According to the 2025 annual accounts
Director · represented by Kathleen Moons
Also active at: Dr. M. Dieltiëns, DR. F. KESTELOOT, DR. J.C. VRYGHEM, OOGHEELKUNDE, Center for sight - Dr. E. Mertens, EQIRIS, MO ACTIVITIES, Bredabaan 552, OAMM +1 more
since 2024
Director · represented by Maria Dieltiëns
Also active at: Dr. M. Dieltiëns, DR. F. KESTELOOT, DR. J.C. VRYGHEM, OOGHEELKUNDE, Center for sight - Dr. E. Mertens, MO ACTIVITIES, Bredabaan 552, OAMM, Oogartsenpraktijk Brugge
since 2024
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 206
9830 Sint-Martens-Latem
Petrus Paulus Rubenslaan 1
9820 Merelbeke-Melle
Active since 18 December 2023
Garenstraat 44
9900 Eeklo
Active since 18 December 2023
Markt 24
9890 Gavere
Active since 18 December 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1004.052.740
- VAT number
- BE 1004.052.740
- Registered office
- Kortrijksesteenweg 206, 9830 Sint-Martens-Latem
- Names & denominations
- Dr. De Wilde Fernand
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2023
- Peppol
- Active · Active since 27 Mar 2025
- Activities · NACE
Activiteiten van medisch specialisten